Invenomic Fund LP
Invenomic Fund LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jan 8, 2026, the fund has sold $45,955,947 of interests to 29 investors since its first sale in Aug 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Invenomic Capital Management LP; Invenomic Private Fund GP LLC; Ali Motamed.
Performance
No returns have been reported for this fund. As a rough guide, Invenomic Capital Management LP, which manages it, disclosed U.S. stock holdings that returned an estimated +4.8% 2026 YTD through Jun 30 (S&P 500: +9.5%), based only on its public 13F filings. Over a longer period, Q3 2024 to Q2 2026, the estimate is +25.4% (S&P 500: +37.2%).
This estimate covers the firm's whole disclosed long U.S. stock portfolio. It is not this fund's return and excludes dividends, fees, shorts, derivatives, bonds, cash and trading within each quarter.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $45,955,947Cumulative sales reported on Form D
- Investors
- 29
- First sale
- Aug 15, 2017
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Invenomic Capital Management LP; Invenomic Private Fund GP LLC; Ali Motamed
- Latest Form D
- Jan 8, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Invenomic Fund LP
What is the minimum investment for Invenomic Fund LP?
Invenomic Fund LP's latest Form D, filed Jan 8, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Invenomic Fund LP?
Invenomic Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Invenomic Fund LP raised?
Invenomic Fund LP reports $45,955,947 sold from 29 investors on its Form D filed Jan 8, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Invenomic Fund LP based?
Invenomic Fund LP is based in Boston, Massachusetts and is managed by Invenomic Capital Management LP.
When did Invenomic Fund LP launch?
Invenomic Fund LP reports its first sale in Aug 2017.
Size compared with every hedge fund
Raised more than 35% of the 475 hedge funds based in Massachusetts, and more than 44% of all 10,197 that report sales.